Israeli Nobel laureate appointed to Protalix BioTherapeutics’ scientific advisory board

Posted on August 6, 2007 • By Deena Levenstein
Category: Science |

HemoglobinProtalix BioTherapeutics has invited Nobel laureate Professor Aaron Ciechanover to join their scientific advisory board.

Protalix is a publicly traded Israeli company (AMEX: PLX) that has developed a proprietary plant cell culture technology and an innovative bioreactor system.

Prof. Ciechanover received the Nobel prize in chemistry along with two other Israelis in 2004 for discovering the ubiquitin-mediated proteolytic system. This has lead to a deeper understanding of how cells control certain biological processes by breaking down specific proteins.

Of his recent appointment, Prof. Ciechanover said, “I am pleased to have the opportunity to join such a highly regarded team of accredited and innovative individuals. The study of protein-based therapeutics is an intriguing field with the potential to provide many benefits to our society, and I look forward to working with Protalix to further explore these possibilities.”

“Protalix BioTherapeutics Appoints Prof. Aaron Ciechanover, a Laureate of the Nobel Prize in Chemistry, to its Scientific Advisory Board”, prnewswire, August 6, 2007.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • bodytext
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google

If you liked this post, be sure to subscribe to our RSS feed.

 

 

  

Leave a Comment

If you would like to make a comment, please fill out the form below.

Name (required)

Email (required)

Website

Comments

1 Comment so far
  1. Israeli Nobel laureate Ciechanover appointed to another advisory board August 15, 2007 3:38 am

    [...] August 6th I wrote about the Israeli Chemistry Nobel laureate and cancer research specialist Prof. Aaron [...]

Subscribe without commenting

Search

Subscribe to israelplug

Categories

Sponsors

 

FlickrIsrael